
At Be Your Kind, we understand that weight loss is not simply about willpower. Your metabolism, hormones, stress levels, nutrition, and lifestyle all play a role in how your body gains and loses weight. Our medically supervised GLP-1 weight loss program is designed to support sustainable, long-term results through personalized care that works with your body – not against it.
Serving clients from Edina, Minneapolis, and across the Twin Cities, our approach combines GLP-1 weight loss medications, lab testing, nutritional support, and ongoing provider guidance to help you build healthier habits and improve overall metabolic health.

Your personalized plan starts here at our Edina weight loss clinic. Each GLP-1 appointment is tailored to you and typically lasts about 30–45 minutes.
Setting you up for success between visits.
At our Edina weight loss clinic, GLP-1s are highly effective when paired with consistent care and lifestyle support. Here’s what to expect after your injection and how to support your body:
GLP-1 medications (glucagon-like peptide-1 receptor agonists) are a class of medications designed to regulate appetite, blood sugar, digestion, and metabolism. These medications help many patients feel fuller longer, reduce cravings, and support gradual, sustainable weight loss when combined with lifestyle changes.
At Be Your Kind, our approach goes beyond prescribing medication alone. We combine comprehensive lab testing, body composition analysis, nutritional guidance, and ongoing provider support to create personalized treatment plans that support long-term metabolic health and sustainable results.
Clinical studies show that many patients using GLP-1 medications such as semaglutide or tirzepatide may lose a meaningful percentage of body weight over time when combined with lifestyle changes. Results vary depending on the medication used, consistency, body composition, nutrition, activity level, and overall metabolic health.
GLP-1 medications support overall fat loss, including visceral fat stored around the abdomen. This is clinically significant because excess abdominal fat is directly linked to insulin resistance, chronic inflammation, and elevated cardiovascular risk. Reducing it can improve metabolic health markers beyond what the scale alone reflects.
Studies show GLP-1 medications may improve cholesterol levels, blood pressure, insulin sensitivity, and other markers associated with metabolic syndrome and cardiovascular disease. Many patients also report improvements in energy, mobility, and overall wellness as weight loss progresses.
Weight loss with GLP-1s has been shown to reduce the risk of conditions like heart disease, diabetes, and metabolic syndrome. Our weight loss clinic provides ongoing support to help patients maintain these long-term benefits.
GLP-1 medications slow digestion and support insulin regulation, helping stabilize blood sugar levels throughout the day. This reduces large fluctuations in appetite and energy that often drive overeating. For individuals managing insulin resistance or pre-diabetes, improved blood sugar control can be one of the most meaningful outcomes of treatment.
Every program at Be Your Kind is built around your individual goals, lab results, medical history, and treatment response. Your provider monitors progress through regular check-ins, adjusting medication, dosing, and lifestyle guidance over time. This ongoing supervision is what separates a medically managed program from an over-the-counter or online-only approach.
Different GLP-1 medications vary in their active ingredients, dosing, appetite suppression effects, and individual response. Some medications are FDA-approved specifically for weight loss while others were originally developed for type 2 diabetes. Your provider will help determine which option aligns best with your health history, goals, and treatment preferences.
The most common side effect is nausea, especially during the first few weeks of treatment or after dose increases. Some patients may also experience constipation, bloating, fatigue, or decreased appetite. At Be Your Kind, we start with the lowest effective dose and gradually increase only when appropriate. Ongoing provider check-ins also help monitor long-term considerations such as thyroid screening, muscle mass preservation, and pancreatitis risk.
Yes, in some cases. Microdosing may help individuals who are sensitive to side effects or prefer a slower adjustment period. Lower starting doses may also help support gradual, sustainable weight loss while preserving muscle mass and minimizing gastrointestinal discomfort.
GLP-1 medications are designed for long-term metabolic health support and may be used safely for extended periods under medical supervision. Many patients continue treatment long-term to help maintain weight loss results and support blood sugar regulation, appetite control, and overall metabolic health.
GLP-1 medications are typically self-administered once weekly at home. Most patients complete monthly follow-up appointments with their provider to monitor progress, review side effects, adjust dosing, and evaluate overall health markers throughout treatment.
No. GLP-1 refers to the medication class known as glucagon-like peptide-1 receptor agonists – a group of medications that regulate appetite, blood sugar, and metabolism. Ozempic and Wegovy are both brand names for semaglutide, a GLP-1 medication. Ozempic is FDA-approved for type 2 diabetes management, while Wegovy is FDA-approved specifically for weight loss.
While semaglutide is one of the most well-known treatment options, it isn’t the only medication available. Some newer medications work on additional hormone pathways involved in appetite regulation and blood sugar control. For example, Mounjaro and Zepbound contain tirzepatide, which activates both GLP-1 and GIP receptors. By targeting two pathways instead of one, tirzepatide may provide another effective option for eligible patients.
At Be Your Kind, your provider will discuss the available treatment options and recommend the medication that best aligns with your health history, lifestyle, and weight loss goals.
FDA-approved GLP-1 medications such as Wegovy and Zepbound are considered safe for most patients when prescribed and monitored appropriately. At Be Your Kind, every program begins with medical screening and lab review to confirm suitability. These medications are not appropriate for everyone – which is exactly why we assess before we prescribe.
Most patients notice appetite changes and reduced cravings within the first 1-2 weeks as the medication begins regulating hunger signals. Visible weight loss typically follows within 4-8 weeks. Peak results in clinical trials are seen between 12-18 months, reflecting the gradual nature of sustainable fat loss. Individual response varies depending on medication, dosage, metabolism, and lifestyle habits.
Be Your Kind
WANT 10% OFF?
Join us for expert-led treatments, thoughtful wellness support, and a community that's here to help you feel like your best self.
By submitting your information, you consent to receive marketing emails from Be Your Kind. Please review our Privacy Policy.